CRT 2023
Atherosclerosis and Vulnerable Plaque
Khady Fall, MD
Director of Operation & Program Manager of Imaging /Physiology
Columbia University Medical Center-NYP
New York, New York, United States
Disclosure(s): Boston Scientific Corporation: Consulting fees or other remuneration (Ongoing)
Zorina S. Galis, PhD
Chief, Vascular Biology and Hypertension
National Institutes of Health
Bethesda, Maryland, United States
Disclosure(s): No financial relationships to disclose
Hector M. Garcia-Garcia, MD, PhD
Director of Invasive Imaging Core Laboratory
MedStar Washington Hospital Center
Washington, District of Columbia, United States
Disclosure(s): No relevant disclosure to display
Francesco Prati, MD
Chief Cardiovascular Department
San Giovanni Hospital Rome, Italy
No relationships to disclose
Hiram G. Bezerra, MD, PhD
Interventional Cardiologist
Tampa General / USF
Tampa, Florida, United States
Disclosure(s): Abbott Vascular: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Gentuity: Advisor (Ongoing), Consultant/Advisory Board (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing)
James A. Goldstein, MD, FSCAI
Director, Research and Education
Beaumont Health System
Royal Oak, Michigan, United States
Disclosure(s): ECLS, Inc which licenses radiation shiled technology to Image Diagnostics, Inc: Intellectual Property/Patents (Ongoing), Major Stockholder (not including mutual funds) (Ongoing), Officer or Board Member (Ongoing), Royalties (Ongoing)
Farouc A. Jaffer, MD, PhD (he/him/his)
Director Coronary Intervention and CTO PCI Program
Massachusetts General Hospital / Harvard Medical School
Boston, Massachusetts, United States
Disclosure(s): Abiomed: Honoraria (Ongoing); Asahi Intecc, Japan: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Canon Medical Systems USA, Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Royalties (Ongoing); DurVena Inc: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); HeartFlow Inc.: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); IMDS: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Intravascular Imaging Incorporated: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Massachusetts General Hospital: Patent Holder (Ongoing), Royalties (Ongoing), University Grants/Research Support (Ongoing); mercator: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave Medical, Inc.: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Siemens: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Spectrawave: Royalties (Ongoing); Teleflex Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Michael H. Joner, MD
Associate Professor Interventional Cardiology
Deutsches Herzzentrum Muenchen
Munich, Bayern, Germany
Disclosure(s): Abbott Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 22, 2022); Alchimedics S.A.S.: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, October 15, 2022); Biotronik: Consultant/Advisory Board (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant Recipient (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cardiac Dimensions: Consultant (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Consultant/Advisory Board (Ongoing), Educational Grant (Ongoing); InfraRedx: Grant/Research Support (Ongoing); ReCor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 19, 2022); Shockwave: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing); Veryan: Consultant (Ongoing), Consulting fees or other remuneration (Ongoing)
Arnav Kumar, MD, MSCR (he/him/his)
Structural Heart & Peripheral Interventions Fellow
Brigham & Women's Hospital
Chestnut Hill, Massachusetts, United States
Disclosure(s): No relevant disclosure to display
Pedro R. Moreno, MD, FACC
Director - Quality Assurance for Cardiology
Mount Sinai Hospital
New York, New York, United States
Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen, Sanofi/Regeneron, Esperion, Novo Nordisk, Akcea: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Natalia Pinilla, MD, PhD (she/her/hers)
Assistant Professor / Interventional Cardiologist
McMaster University
Burlington, Ontario, Canada
Disclosure(s): Abbott: Advisory Committee/Board Member (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Educational Grant (Ongoing); Amgen: Consultant (Ongoing); Conavi: Consultant (Ongoing); Novartis: Consultant (Ongoing); Philips: Advisory Committee/Board Member (Ongoing)